25 XP   0   0   10

Jinhe Biotechnology Co Ltd
Buy, Hold or Sell?

Let's analyse Jinhe together

PenkeI guess you are interested in Jinhe Biotechnology Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jinhe Biotechnology Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jinhe Biotechnology Co Ltd

I send you an email if I find something interesting about Jinhe Biotechnology Co Ltd.

Quick analysis of Jinhe (30 sec.)










What can you expect buying and holding a share of Jinhe? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.11
Expected worth in 1 year
¥1.72
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥-1.18
Return On Investment
-31.0%

For what price can you sell your share?

Current Price per Share
¥3.82
Expected price per share
¥2.91 - ¥4.52
How sure are you?
50%

1. Valuation of Jinhe (5 min.)




Live pricePrice per Share (EOD)

¥3.82

Intrinsic Value Per Share

¥-7.44 - ¥-1.67

Total Value Per Share

¥-4.34 - ¥1.44

2. Growth of Jinhe (5 min.)




Is Jinhe growing?

Current yearPrevious yearGrowGrow %
How rich?$334.6m$372.1m-$37.4m-11.2%

How much money is Jinhe making?

Current yearPrevious yearGrowGrow %
Making money$10.4m$12.9m-$2.5m-24.4%
Net Profit Margin3.6%4.5%--

How much money comes from the company's main activities?

3. Financial Health of Jinhe (5 min.)




What can you expect buying and holding a share of Jinhe? (5 min.)

Welcome investor! Jinhe's management wants to use your money to grow the business. In return you get a share of Jinhe.

What can you expect buying and holding a share of Jinhe?

First you should know what it really means to hold a share of Jinhe. And how you can make/lose money.

Speculation

The Price per Share of Jinhe is ¥3.82. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jinhe.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jinhe, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.11. Based on the TTM, the Book Value Change Per Share is ¥-0.35 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jinhe.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.3%0.010.3%0.020.4%0.020.6%0.020.5%
Usd Book Value Change Per Share-0.05-1.3%-0.05-1.3%0.174.4%0.030.7%0.030.7%
Usd Dividend Per Share0.010.2%0.010.2%0.020.5%0.020.6%0.020.5%
Usd Total Gains Per Share-0.04-1.1%-0.04-1.1%0.194.9%0.051.3%0.051.2%
Usd Price Per Share0.71-0.71-0.85-0.76-1.51-
Price to Earnings Ratio53.10-53.10-50.90-37.67-83.90-
Price-to-Total Gains Ratio-17.39--17.39-4.55-9.88-57.85-
Price to Book Ratio1.65-1.65-1.77-2.11-7.14-
Price-to-Total Gains Ratio-17.39--17.39-4.55-9.88-57.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.52716
Number of shares1896
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.02
Usd Book Value Change Per Share-0.050.03
Usd Total Gains Per Share-0.040.05
Gains per Quarter (1896 shares)-77.3596.80
Gains per Year (1896 shares)-309.42387.19
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
154-364-319176211377
2109-728-628352423764
3163-1091-9375286341151
4218-1455-12467038451538
5272-1819-155587910571925
6326-2183-1864105512682312
7381-2547-2173123114792699
8435-2910-2482140716913086
9489-3274-2791158319023473
10544-3638-3100175921133860

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%12.02.00.085.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%13.01.00.092.9%

Fundamentals of Jinhe

About Jinhe Biotechnology Co Ltd

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera. It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. Jinhe Biotechnology CO., LTD. was founded in 1990 and is based in Dalian, China.

Fundamental data was last updated by Penke on 2024-04-14 18:51:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Jinhe Biotechnology Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jinhe earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jinhe to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 3.6% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jinhe Biotechnology Co Ltd:

  • The MRQ is 3.6%. The company is making a profit. +1
  • The TTM is 3.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.6%TTM3.6%0.0%
TTM3.6%YOY4.5%-1.0%
TTM3.6%5Y7.0%-3.4%
5Y7.0%10Y8.3%-1.3%
1.1.2. Return on Assets

Shows how efficient Jinhe is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jinhe to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.7% Return on Assets means that Jinhe generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jinhe Biotechnology Co Ltd:

  • The MRQ is 1.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.7%TTM1.7%0.0%
TTM1.7%YOY2.3%-0.6%
TTM1.7%5Y3.6%-1.9%
5Y3.6%10Y4.7%-1.1%
1.1.3. Return on Equity

Shows how efficient Jinhe is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jinhe to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.4% Return on Equity means Jinhe generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jinhe Biotechnology Co Ltd:

  • The MRQ is 3.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.4%TTM3.4%0.0%
TTM3.4%YOY3.9%-0.5%
TTM3.4%5Y7.1%-3.7%
5Y7.1%10Y8.2%-1.1%

1.2. Operating Efficiency of Jinhe Biotechnology Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jinhe is operating .

  • Measures how much profit Jinhe makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jinhe to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 7.7% means the company generated ¥0.08  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jinhe Biotechnology Co Ltd:

  • The MRQ is 7.7%. The company is operating less efficient.
  • The TTM is 7.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ7.7%TTM7.7%0.0%
TTM7.7%YOY9.8%-2.0%
TTM7.7%5Y11.2%-3.4%
5Y11.2%10Y10.1%+1.1%
1.2.2. Operating Ratio

Measures how efficient Jinhe is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.63 means that the operating costs are ¥1.63 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jinhe Biotechnology Co Ltd:

  • The MRQ is 1.630. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.630. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.630TTM1.6300.000
TTM1.630YOY1.576+0.054
TTM1.6305Y1.538+0.092
5Y1.53810Y1.354+0.184

1.3. Liquidity of Jinhe Biotechnology Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jinhe is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.05 means the company has ¥1.05 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jinhe Biotechnology Co Ltd:

  • The MRQ is 1.049. The company is just able to pay all its short-term debts.
  • The TTM is 1.049. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.049TTM1.0490.000
TTM1.049YOY1.418-0.369
TTM1.0495Y1.129-0.080
5Y1.12910Y0.953+0.176
1.3.2. Quick Ratio

Measures if Jinhe is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jinhe to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.25 means the company can pay off ¥0.25 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jinhe Biotechnology Co Ltd:

  • The MRQ is 0.246. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.246. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.246TTM0.2460.000
TTM0.246YOY0.434-0.188
TTM0.2465Y0.327-0.081
5Y0.32710Y0.480-0.153

1.4. Solvency of Jinhe Biotechnology Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jinhe assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jinhe to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.46 means that Jinhe assets are financed with 46.2% credit (debt) and the remaining percentage (100% - 46.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jinhe Biotechnology Co Ltd:

  • The MRQ is 0.462. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.462. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.462TTM0.4620.000
TTM0.462YOY0.337+0.125
TTM0.4625Y0.441+0.020
5Y0.44110Y0.398+0.043
1.4.2. Debt to Equity Ratio

Measures if Jinhe is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jinhe to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 93.6% means that company has ¥0.94 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jinhe Biotechnology Co Ltd:

  • The MRQ is 0.936. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.936. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.936TTM0.9360.000
TTM0.936YOY0.561+0.375
TTM0.9365Y0.870+0.067
5Y0.87010Y0.746+0.124

2. Market Valuation of Jinhe Biotechnology Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jinhe generates.

  • Above 15 is considered overpriced but always compare Jinhe to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 53.10 means the investor is paying ¥53.10 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jinhe Biotechnology Co Ltd:

  • The EOD is 39.464. Based on the earnings, the company is overpriced. -1
  • The MRQ is 53.100. Based on the earnings, the company is expensive. -2
  • The TTM is 53.100. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD39.464MRQ53.100-13.637
MRQ53.100TTM53.1000.000
TTM53.100YOY50.898+2.203
TTM53.1005Y37.666+15.434
5Y37.66610Y83.897-46.231
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jinhe Biotechnology Co Ltd:

  • The EOD is -10.736. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.446. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -14.446. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.736MRQ-14.446+3.710
MRQ-14.446TTM-14.4460.000
TTM-14.446YOY-20.733+6.287
TTM-14.4465Y5.179-19.625
5Y5.17910Y-146.321+151.500
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jinhe is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Jinhe Biotechnology Co Ltd:

  • The EOD is 1.229. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.654. Based on the equity, the company is underpriced. +1
  • The TTM is 1.654. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.229MRQ1.654-0.425
MRQ1.654TTM1.6540.000
TTM1.654YOY1.774-0.120
TTM1.6545Y2.110-0.456
5Y2.11010Y7.143-5.033
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jinhe Biotechnology Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.348-0.3480%1.213-129%0.202-272%0.200-274%
Book Value Per Share--3.1083.1080%3.455-10%2.680+16%2.126+46%
Current Ratio--1.0491.0490%1.418-26%1.129-7%0.953+10%
Debt To Asset Ratio--0.4620.4620%0.337+37%0.441+5%0.398+16%
Debt To Equity Ratio--0.9360.9360%0.561+67%0.870+8%0.746+26%
Dividend Per Share--0.0520.0520%0.134-61%0.168-69%0.130-60%
Eps--0.0970.0970%0.120-20%0.163-41%0.151-36%
Free Cash Flow Per Share---0.356-0.3560%-0.296-17%-0.104-71%-0.050-86%
Free Cash Flow To Equity Per Share---0.163-0.1630%0.279-158%0.049-434%0.129-227%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.669--------
Intrinsic Value_10Y_min---7.444--------
Intrinsic Value_1Y_max---0.075--------
Intrinsic Value_1Y_min---0.337--------
Intrinsic Value_3Y_max---0.296--------
Intrinsic Value_3Y_min---1.372--------
Intrinsic Value_5Y_max---0.602--------
Intrinsic Value_5Y_min---2.794--------
Market Cap2981212101.120-35%4011371125.7204011371125.7200%4783989299.740-16%4293882793.060-7%8519867579.186-53%
Net Profit Margin--0.0360.0360%0.045-21%0.070-49%0.083-57%
Operating Margin--0.0770.0770%0.098-21%0.112-31%0.101-23%
Operating Ratio--1.6301.6300%1.576+3%1.538+6%1.354+20%
Pb Ratio1.229-35%1.6541.6540%1.774-7%2.110-22%7.143-77%
Pe Ratio39.464-35%53.10053.1000%50.898+4%37.666+41%83.897-37%
Price Per Share3.820-35%5.1405.1400%6.130-16%5.502-7%10.917-53%
Price To Free Cash Flow Ratio-10.736+26%-14.446-14.4460%-20.733+44%5.179-379%-146.321+913%
Price To Total Gains Ratio-12.921+26%-17.386-17.3860%4.552-482%9.879-276%57.852-130%
Quick Ratio--0.2460.2460%0.434-43%0.327-25%0.480-49%
Return On Assets--0.0170.0170%0.023-27%0.036-53%0.047-65%
Return On Equity--0.0340.0340%0.039-12%0.071-52%0.082-58%
Total Gains Per Share---0.296-0.2960%1.347-122%0.370-180%0.330-189%
Usd Book Value--334679900.452334679900.4520%372116195.423-10%288638640.017+16%228943273.491+46%
Usd Book Value Change Per Share---0.048-0.0480%0.167-129%0.028-272%0.028-274%
Usd Book Value Per Share--0.4290.4290%0.477-10%0.370+16%0.293+46%
Usd Dividend Per Share--0.0070.0070%0.018-61%0.023-69%0.018-60%
Usd Eps--0.0130.0130%0.017-20%0.022-41%0.021-36%
Usd Free Cash Flow---38320612.738-38320612.7380%-31842611.375-17%-11151076.671-71%-4813938.600-87%
Usd Free Cash Flow Per Share---0.049-0.0490%-0.041-17%-0.014-71%-0.007-86%
Usd Free Cash Flow To Equity Per Share---0.023-0.0230%0.039-158%0.007-434%0.018-227%
Usd Market Cap411407269.955-35%553569215.349553569215.3490%660190523.364-16%592555825.442-7%1175741725.928-53%
Usd Price Per Share0.527-35%0.7090.7090%0.846-16%0.759-7%1.507-53%
Usd Profit--10424984.98710424984.9870%12970948.556-20%17537807.350-41%16287802.625-36%
Usd Revenue--292933333.804292933333.8040%286762444.762+2%260173806.536+13%209910438.528+40%
Usd Total Gains Per Share---0.041-0.0410%0.186-122%0.051-180%0.046-189%
 EOD+4 -4MRQTTM+0 -0YOY+3 -325Y+7 -2810Y+8 -27

3.2. Fundamental Score

Let's check the fundamental score of Jinhe Biotechnology Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1539.464
Price to Book Ratio (EOD)Between0-11.229
Net Profit Margin (MRQ)Greater than00.036
Operating Margin (MRQ)Greater than00.077
Quick Ratio (MRQ)Greater than10.246
Current Ratio (MRQ)Greater than11.049
Debt to Asset Ratio (MRQ)Less than10.462
Debt to Equity Ratio (MRQ)Less than10.936
Return on Equity (MRQ)Greater than0.150.034
Return on Assets (MRQ)Greater than0.050.017
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Jinhe Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.834
Ma 20Greater thanMa 503.798
Ma 50Greater thanMa 1003.729
Ma 100Greater thanMa 2004.176
OpenGreater thanClose3.790
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,505,583
Total Liabilities2,080,366
Total Stockholder Equity2,221,590
 As reported
Total Liabilities 2,080,366
Total Stockholder Equity+ 2,221,590
Total Assets = 4,505,583

Assets

Total Assets4,505,583
Total Current Assets1,746,515
Long-term Assets2,759,067
Total Current Assets
Cash And Cash Equivalents 491,368
Net Receivables 409,498
Inventory 675,909
Other Current Assets 62,260
Total Current Assets  (as reported)1,746,515
Total Current Assets  (calculated)1,639,034
+/- 107,481
Long-term Assets
Property Plant Equipment 1,623,192
Goodwill 298,913
Intangible Assets 710,712
Long-term Assets Other 102,163
Long-term Assets  (as reported)2,759,067
Long-term Assets  (calculated)2,734,980
+/- 24,087

Liabilities & Shareholders' Equity

Total Current Liabilities1,664,636
Long-term Liabilities415,729
Total Stockholder Equity2,221,590
Total Current Liabilities
Short Long Term Debt 1,246,477
Accounts payable 263,108
Other Current Liabilities 71,320
Total Current Liabilities  (as reported)1,664,636
Total Current Liabilities  (calculated)1,580,905
+/- 83,732
Long-term Liabilities
Long term Debt 296,223
Capital Lease Obligations Min Short Term Debt7,670
Other Liabilities 111,836
Deferred Long Term Liability 88,319
Long-term Liabilities  (as reported)415,729
Long-term Liabilities  (calculated)504,049
+/- 88,319
Total Stockholder Equity
Common Stock780,422
Retained Earnings 679,483
Other Stockholders Equity 4,613
Total Stockholder Equity (as reported)2,221,590
Total Stockholder Equity (calculated)1,464,519
+/- 757,071
Other
Capital Stock780,422
Common Stock Shares Outstanding 780,422
Net Debt 1,051,332
Net Invested Capital 3,764,290
Net Tangible Assets 1,292,960
Net Working Capital 81,879
Property Plant and Equipment Gross 1,623,192



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
> Total Assets 
618,588
623,923
670,839
1,003,373
1,016,874
1,518,628
1,885,203
2,662,338
2,959,912
3,335,354
3,344,279
3,376,867
4,064,526
4,505,583
4,505,5834,064,5263,376,8673,344,2793,335,3542,959,9122,662,3381,885,2031,518,6281,016,8741,003,373670,839623,923618,588
   > Total Current Assets 
0
0
0
0
0
0
801,936
865,203
1,080,306
1,315,695
1,240,718
1,240,147
1,649,952
1,746,515
1,746,5151,649,9521,240,1471,240,7181,315,6951,080,306865,203801,936000000
       Cash And Cash Equivalents 
77,439
61,354
87,844
373,458
275,220
228,778
225,419
239,379
345,289
491,812
361,906
314,799
517,659
491,368
491,368517,659314,799361,906491,812345,289239,379225,419228,778275,220373,45887,84461,35477,439
       Short-term Investments 
0
0
0
0
0
0
0
26,000
0
0
0
0
0
0
00000026,0000000000
       Net Receivables 
91,136
89,924
117,901
162,535
122,888
181,245
199,583
223,677
354,508
420,925
405,725
301,126
504,816
409,498
409,498504,816301,126405,725420,925354,508223,677199,583181,245122,888162,535117,90189,92491,136
       Other Current Assets 
27,689
7,896
12,192
18,222
51,876
54,162
66,544
75,806
43,716
36,908
41,609
63,130
49,967
62,260
62,26049,96763,13041,60936,90843,71675,80666,54454,16251,87618,22212,1927,89627,689
   > Long-term Assets 
0
0
0
0
0
0
0
1,797,135
1,879,605
2,019,659
2,103,561
2,136,720
2,414,574
2,759,067
2,759,0672,414,5742,136,7202,103,5612,019,6591,879,6051,797,1350000000
       Property Plant Equipment 
300,655
319,596
342,028
330,005
437,706
489,167
565,442
682,791
766,903
874,643
973,071
1,045,112
1,208,810
1,623,192
1,623,1921,208,8101,045,112973,071874,643766,903682,791565,442489,167437,706330,005342,028319,596300,655
       Goodwill 
0
0
0
0
0
40,385
7,710
373,706
354,317
351,305
326,693
309,941
295,968
298,913
298,913295,968309,941326,693351,305354,317373,7067,71040,38500000
       Long Term Investments 
0
0
0
0
0
0
225,234
776
1,384
2,140
0
0
0
0
00002,1401,384776225,234000000
       Intangible Assets 
12,389
30,980
595
554
2,620
254,791
277,107
697,052
689,328
726,443
735,217
683,375
714,447
710,712
710,712714,447683,375735,217726,443689,328697,052277,107254,7912,62055459530,98012,389
       Long-term Assets Other 
0
0
0
0
0
0
0
30,030
55,025
52,530
52,572
69,110
178,592
102,163
102,163178,59269,11052,57252,53055,02530,0300000000
> Total Liabilities 
422,559
369,094
336,438
139,826
116,806
562,501
830,677
1,078,206
1,322,593
1,555,963
1,537,400
1,626,926
1,368,032
2,080,366
2,080,3661,368,0321,626,9261,537,4001,555,9631,322,5931,078,206830,677562,501116,806139,826336,438369,094422,559
   > Total Current Liabilities 
406,672
306,402
315,164
122,358
100,104
226,025
811,988
529,054
855,124
1,102,888
1,145,351
1,373,061
1,163,685
1,664,636
1,664,6361,163,6851,373,0611,145,3511,102,888855,124529,054811,988226,025100,104122,358315,164306,402406,672
       Short-term Debt 
0
0
0
0
0
0
129,872
296,326
598,000
884,115
881,714
0
0
0
000881,714884,115598,000296,326129,872000000
       Short Long Term Debt 
0
0
0
0
0
0
129,872
296,326
598,000
884,115
881,714
1,115,411
833,899
1,246,477
1,246,477833,8991,115,411881,714884,115598,000296,326129,872000000
       Accounts payable 
40,535
58,952
33,843
51,273
52,666
108,481
157,721
120,772
160,370
119,758
151,992
96,980
122,037
263,108
263,108122,03796,980151,992119,758160,370120,772157,721108,48152,66651,27333,84358,95240,535
       Other Current Liabilities 
82,237
17,450
25,821
11,085
17,438
18,592
15,907
54,995
37,937
23,300
38,489
38,911
83,900
71,320
71,32083,90038,91138,48923,30037,93754,99515,90718,59217,43811,08525,82117,45082,237
   > Long-term Liabilities 
0
0
0
0
0
0
0
549,152
467,469
453,074
392,049
253,864
204,347
415,729
415,729204,347253,864392,049453,074467,469549,1520000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
-129,872
-296,326
-598,000
-884,115
-881,714
955
0
7,670
7,6700955-881,714-884,115-598,000-296,326-129,872000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
203,559
93,727
76,087
26,223
11,914
11,642
0
011,64211,91426,22376,08793,727203,5590000000
       Deferred Long Term Liability 
0
0
0
0
0
0
5,682
28,553
51,258
53,437
68,710
69,449
75,351
88,319
88,31975,35169,44968,71053,43751,25828,5535,682000000
> Total Stockholder Equity
184,840
242,290
322,498
864,404
900,577
950,578
1,035,121
1,496,389
1,526,519
1,677,943
1,678,926
1,614,883
2,438,211
2,221,590
2,221,5902,438,2111,614,8831,678,9261,677,9431,526,5191,496,3891,035,121950,578900,577864,404322,498242,290184,840
   Common Stock
81,690
81,690
81,690
108,920
108,920
217,840
217,840
635,290
635,290
635,290
635,290
635,290
780,422
780,422
780,422780,422635,290635,290635,290635,290635,290217,840217,840108,920108,92081,69081,69081,690
   Retained Earnings 
33,147
80,387
149,524
229,639
256,046
234,981
317,850
431,156
444,287
588,857
614,974
573,476
603,940
679,483
679,483603,940573,476614,974588,857444,287431,156317,850234,981256,046229,639149,52480,38733,147
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
1,416
5,607
1,568
8,675
6,300
-15,819
-25,198
4,613
4,613-25,198-15,8196,3008,6751,5685,6071,416000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,059,697
Cost of Revenue-1,424,863
Gross Profit634,834634,834
 
Operating Income (+$)
Gross Profit634,834
Operating Expense-1,886,871
Operating Income172,827-1,252,036
 
Operating Expense (+$)
Research Development72,055
Selling General Administrative222,562
Selling And Marketing Expenses-
Operating Expense1,886,871294,617
 
Net Interest Income (+$)
Interest Income1,144
Interest Expense-53,758
Other Finance Cost-26,463
Net Interest Income-79,076
 
Pretax Income (+$)
Operating Income172,827
Net Interest Income-79,076
Other Non-Operating Income Expenses-
Income Before Tax (EBT)88,996172,827
EBIT - interestExpense = -53,758
76,151
129,909
Interest Expense53,758
Earnings Before Interest and Taxes (EBIT)-142,754
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax88,996
Tax Provision--4,842
Net Income From Continuing Ops93,83993,839
Net Income76,151
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-79,076
 

Technical Analysis of Jinhe
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jinhe. The general trend of Jinhe is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jinhe's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jinhe Biotechnology Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.36 < 4.47 < 4.52.

The bearish price targets are: 3.4 > 2.91.

Tweet this
Jinhe Biotechnology Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jinhe Biotechnology Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jinhe Biotechnology Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jinhe Biotechnology Co Ltd. The current macd is -0.03463767.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jinhe price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Jinhe. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Jinhe price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jinhe Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJinhe Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jinhe Biotechnology Co Ltd. The current adx is 18.96.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Jinhe shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Jinhe Biotechnology Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jinhe Biotechnology Co Ltd. The current sar is 3.4084.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jinhe Biotechnology Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jinhe Biotechnology Co Ltd. The current rsi is 51.83. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Jinhe Biotechnology Co Ltd Daily Relative Strength Index (RSI) ChartJinhe Biotechnology Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jinhe Biotechnology Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jinhe price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jinhe Biotechnology Co Ltd Daily Stochastic Oscillator ChartJinhe Biotechnology Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jinhe Biotechnology Co Ltd. The current cci is 1.51937199.

Jinhe Biotechnology Co Ltd Daily Commodity Channel Index (CCI) ChartJinhe Biotechnology Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jinhe Biotechnology Co Ltd. The current cmo is 10.16.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Jinhe Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJinhe Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jinhe Biotechnology Co Ltd. The current willr is -26.31578947.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jinhe is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jinhe Biotechnology Co Ltd Daily Williams %R ChartJinhe Biotechnology Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jinhe Biotechnology Co Ltd.

Jinhe Biotechnology Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jinhe Biotechnology Co Ltd. The current atr is 0.15876622.

Jinhe Biotechnology Co Ltd Daily Average True Range (ATR) ChartJinhe Biotechnology Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jinhe Biotechnology Co Ltd. The current obv is 104,780,076.

Jinhe Biotechnology Co Ltd Daily On-Balance Volume (OBV) ChartJinhe Biotechnology Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jinhe Biotechnology Co Ltd. The current mfi is 53.33.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Jinhe Biotechnology Co Ltd Daily Money Flow Index (MFI) ChartJinhe Biotechnology Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jinhe Biotechnology Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Jinhe Biotechnology Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jinhe Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.834
Ma 20Greater thanMa 503.798
Ma 50Greater thanMa 1003.729
Ma 100Greater thanMa 2004.176
OpenGreater thanClose3.790
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jinhe with someone you think should read this too:
  • Are you bullish or bearish on Jinhe? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jinhe? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jinhe Biotechnology Co Ltd

I send you an email if I find something interesting about Jinhe Biotechnology Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jinhe Biotechnology Co Ltd.

Receive notifications about Jinhe Biotechnology Co Ltd in your mailbox!